Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cabotegravir oral - ViiV Healthcare

Next Previous
X
Search
Drug Profile

Cabotegravir oral - ViiV Healthcare

Alternative Names: 1265744 oral; Cabenuva; Cabotegravir sodium oral; GSK-1265744 oral; GSK-1265744A oral; GSK-1265744B oral; GSK-744 oral; Oral CAB - ViiV Healthcare; S-265744 oral; S-265744B oral; S/GSK-1265744 oral; VOCABRIA

Latest Information Update: 03 May 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shionogi - GlaxoSmithKline (JV)
  • Developer National Institute of Allergy and Infectious Diseases; ViiV Healthcare
  • Class Amides; Antiretrovirals; Fluorobenzenes; Oxazoles; Pyrazines; Pyridones; Small molecules
  • Mechanism of Action HIV integrase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed HIV-1 infections
  • Preregistration HIV infections

Most Recent Events

  • 03 Mar 2024 Adverse events and pharmacokinetics data from a phase I/II MOCHA trial inHIV-1 infections presented at the 31st Conference on Retroviruses and Opportunistic Infections 2024 (CROI-2024)
  • 26 Jul 2023 Preregistration for HIV infections in China (PO) prior to July 2023
  • 26 Jul 2023 GSK anticipates regulatory decision from NMPA for HIV infections in 2H 2023 (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top